SB
Sino Biopharmaceutical Limited
SBHMY · OTC
$14.54 -2.85% (-$0.43)
1M +21.07%
Market Cap ¥86.6B
P/E Ratio 37.99x
Div. Yield 2.11%
ROE 7.16%
Bulios Fair Price
$19.22
32.2% upside
Current Price
$14.54
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SBHMY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
62 /100
Fair P/FCF 11.41x
P/E 37.99x
P/B 2.82x
Growth
53 /100
Stable FCF growth 18.51%
EPS growth 2.70%
Book val. growth 1.05%
Profitability
87 /100
Strong Op. margin 21.40%
Gross margin 82.07%
FCF margin 24.51%
Quality
39 /100
Average ROA 3.00%
ROIC 8.65%
Asset turnover 0.41x
Debt
84 /100
Low Int. coverage 24.48x
Debt/Equity 0.52x
Net debt/EBITDA 1.12x
Stability
75 /100
Stable EPS volatility 66.95%
Beta 0.61x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SBHMY
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
S. Y. Tse
Employees
21,435
Headquarters
Hong Kong